CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells

Grant R Campbell1, Stephen A Spector

  • 1Department of Pediatrics, University of California San Diego, La Jolla, California 92093-0672, USA.

Summary

Chemokine ligand 2 (CCL2) increases susceptibility to human immunodeficiency virus type 1 (HIV-1) infection in CD4(+) T cells. CCL2 up-regulates CXCR4, enhancing viral entry and infection late in HIV-1 disease.